乳房 - 男性的临床试验
总计25097个结果
-
Icahn School of Medicine at Mount SinaiNew York University; National Institute on Deafness and Other Communication Disorders (NIDCD); Ohio University 和其他合作者招聘中
-
Icahn School of Medicine at Mount SinaiNational Institute on Deafness and Other Communication Disorders (NIDCD)完全的
-
National Taiwan University Hospital尚未招聘对抗生素无反应的 MALT 淋巴瘤 | 复发性 MALT 型结外边缘区 B 细胞淋巴瘤 | 难治性结外边缘区 B 细胞淋巴瘤 (MALT)台湾
-
Organon and CoInstitute for Applied Economics and Health Research Aps完全的
-
Salah Azaïz Cancer Institute未知
-
Centro Hospitalar Lisboa OcidentalInstituto Nacional de Medicina Legal e Ciências Forenses, Delegação do Sul未知男性乳腺癌 | 女性乳腺癌
-
Taipei City Hospital完全的PRU(血小板反应单位) | APT(抗血小板治疗) | HOTPR(High on Treat Platelet Reactivity)台湾
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC完全的
-
University of WashingtonNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的
-
University of WashingtonNational Cancer Institute (NCI)撤销
-
National Cancer Institute (NCI)终止
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)招聘中
-
National Cancer Institute (NCI)完全的
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene Corporation终止
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
University of WashingtonNational Cancer Institute (NCI)终止
-
Innocrin Pharmaceutical完全的乳腺癌 | 晚期乳腺癌 | 转移性乳腺癌 | 三阴性乳腺癌 | 男性乳腺癌 | ER+乳腺癌 | 乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
University of Chicago完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的炎性乳腺癌 | 男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Mayo ClinicMarker Therapeutics, Inc.完全的HER2阳性乳腺癌 | 男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
National Cancer Institute (NCI)完全的男性乳腺癌 | IV 期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University Cancer Institute完全的HER2阳性乳腺癌 | 男性乳腺癌 | IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌美国